These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 21378298)
1. Special considerations for treatment of type 2 diabetes mellitus in the elderly. Fravel MA; McDanel DL; Ross MB; Moores KG; Starry MJ Am J Health Syst Pharm; 2011 Mar; 68(6):500-9. PubMed ID: 21378298 [TBL] [Abstract][Full Text] [Related]
2. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL; Figgitt DP Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [TBL] [Abstract][Full Text] [Related]
3. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ismail-Beigi F; Moghissi E; Tiktin M; Hirsch IB; Inzucchi SE; Genuth S Ann Intern Med; 2011 Apr; 154(8):554-9. PubMed ID: 21502652 [TBL] [Abstract][Full Text] [Related]
4. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison. Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152 [TBL] [Abstract][Full Text] [Related]
5. The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis. Ma J; Yang W; Fang N; Zhu W; Wei M Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):596-603. PubMed ID: 19819121 [TBL] [Abstract][Full Text] [Related]
6. Risks and benefits of attaining HbA(1c) goals: examining the evidence. Shubrook JH J Am Osteopath Assoc; 2010 Jul; 110(7 Suppl 7):eS7-12. PubMed ID: 20644204 [TBL] [Abstract][Full Text] [Related]
7. [Hypoglycemia and cardiovascular risk]. Avogaro A G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):4S-12S. PubMed ID: 25623545 [TBL] [Abstract][Full Text] [Related]
8. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study. Yurgin N; Secnik K; Lage MJ Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823 [TBL] [Abstract][Full Text] [Related]
9. Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes. Lipska KJ; Krumholz H; Soones T; Lee SJ JAMA; 2016 Mar; 315(10):1034-45. PubMed ID: 26954412 [TBL] [Abstract][Full Text] [Related]
10. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison. Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076 [TBL] [Abstract][Full Text] [Related]
11. Cardiac risk factors and hypoglycemia in an elderly patient: how good is good enough? Triplitt C Consult Pharm; 2010 Jun; 25 Suppl B():19-27. PubMed ID: 20726379 [TBL] [Abstract][Full Text] [Related]
12. Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study. Lewin A; Lipetz R; Wu J; Schwartz S Clin Ther; 2007 May; 29(5):844-855. PubMed ID: 17697903 [TBL] [Abstract][Full Text] [Related]
13. Treatment of patients over 64 years of age with type 2 diabetes: experience from nateglinide pooled database retrospective analysis. Del Prato S; Heine RJ; Keilson L; Guitard C; Shen SG; Emmons RP Diabetes Care; 2003 Jul; 26(7):2075-80. PubMed ID: 12832316 [TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of preprandial or postprandial Humalog Mix75/25 versus glyburide in patients 60 to 80 years of age with type 2 diabetes mellitus. Herz M; Sun B; Milicevic Z; Erickson P; Fövènyi J; Grzywa M; Pelikanova T Clin Ther; 2002 Jan; 24(1):73-86. PubMed ID: 11833837 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies. Meier M; Hummel M Vasc Health Risk Manag; 2009; 5():859-71. PubMed ID: 19898642 [TBL] [Abstract][Full Text] [Related]
16. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia. Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078 [TBL] [Abstract][Full Text] [Related]
17. Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Monami M; Candido R; Pintaudi B; Targher G; Mannucci E; Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2539-2546. PubMed ID: 34158243 [TBL] [Abstract][Full Text] [Related]
18. Review of the therapeutic uses of liraglutide. Ryan GJ; Foster KT; Jobe LJ Clin Ther; 2011 Jul; 33(7):793-811. PubMed ID: 21741090 [TBL] [Abstract][Full Text] [Related]
19. Insulin analogs for the management of type 2 diabetes. Taylor JR; Campbell KM Am J Health Syst Pharm; 2013 Feb; 70(4):320-34. PubMed ID: 23370139 [TBL] [Abstract][Full Text] [Related]
20. Safety of exenatide once weekly in patients with type 2 diabetes mellitus treated with a thiazolidinedione alone or in combination with metformin for 2 years. Norwood P; Liutkus JF; Haber H; Pintilei E; Boardman MK; Trautmann ME Clin Ther; 2012 Oct; 34(10):2082-90. PubMed ID: 23031623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]